Back
Protalix BioTherapeutics Stock Price Chart
Sponsored
PLX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.70
Seasonality Move:
86.81%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight selling pressure.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.55 | Buy |
20-day SMA: | 1.35 | Buy |
50-day SMA: | 1.18 | Buy |
200-day SMA: | 1.19 | Buy |
8-day EMA: | 1.56 | Buy |
20-day EMA: | 1.39 | Buy |
50-day EMA: | 1.24 | Buy |
200-day EMA: | 1.23 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 74.21 | Buy |
Chaikin Money Flow: | -272804 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.08 - 1.5) | Buy |
Bollinger Bands (100): | (0.95 - 1.27) | Buy |
Protalix BioTherapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.69 while PLX 8-day simple moving average is 1.55, which is a Buy signal.
- The stock price of PLX is 1.69 while Protalix BioTherapeutics 20-day SMA is 1.35, which makes it a Buy.
- Protalix BioTherapeutics 50-day simple moving average is 1.18 while PLX share price is 1.69, making it a Buy technically.
- PLX stock price is 1.69 and Protalix BioTherapeutics 200-day simple moving average is 1.19, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Buy
The current Protalix BioTherapeutics [PLX] share price is $1.69. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
124.44M
Price in USD:
1.69
Share Volume:
545.61K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.90
52-Week Low:
0.82
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.69 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.69 while PLX 8-day exponential moving average is 1.56, which is a Buy signal.
- The stock price of PLX is 1.69 while Protalix BioTherapeutics 20-day EMA is 1.39, which makes it a Buy.
- Protalix BioTherapeutics 50-day exponential moving average is 1.24 while PLX share price is 1.69, making it a Buy technically.
- PLX stock price is 1.69 and Protalix BioTherapeutics 200-day simple moving average is 1.23, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Protalix BioTherapeutics is a Buy
- Protalix BioTherapeutics Relative Strength Index (RSI) is 74.21, which suggest Protalix BioTherapeutics is overbought
- The Bollinger Bands (25) for Protalix BioTherapeutics is (1.08 - 1.5), which suggest Protalix BioTherapeutics is a Buy
- The Bollinger Bands (100) for Protalix BioTherapeutics is (0.95 - 1.27), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.